Q96RR1 (PEO1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 103.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Twinkle protein, mitochondrial EC=3.6.4.12 Alternative name(s): Progressive external ophthalmoplegia 1 protein T7 gp4-like protein with intramitochondrial nucleoid localization T7-like mitochondrial DNA helicase | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 684 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Involved in mitochondrial DNA (mtDNA) metabolism. Could function as an adenine nucleotide-dependent DNA helicase. Function inferred to be critical for lifetime maintenance of mtDNA integrity. In vitro, forms in combination with POLG, a processive replication machinery, which can use double-stranded DNA (dsDNA) as template to synthesize single-stranded DNA (ssDNA) molecules. May be a key regulator of mtDNA copy number in mammals. Ref.8 Ref.9 |
| Catalytic activity | ATP + H2O = ADP + phosphate. |
| Subunit structure | Forms multimers in vitro, including hexamers. Interacts with POLG in vitro. Ref.9 |
| Subcellular location | Mitochondrion matrix › mitochondrion nucleoid. Note: Colocalizes with mtDNA in mitochondrial nucleoids, a nucleoproteins complex consisting of a number of copies of proteins associated with mtDNA, probably involved in mtDNA maintenance and expression. Ref.1 |
| Tissue specificity | High relative levels in skeletal muscle, testis and pancreas. Lower levels of expression in the heart, brain, placenta, lung, liver, kidney, spleen, thymus, prostate, ovary, small intestine, colon and leukocytes. Expression is coregulated with MRPL43. Ref.1 Ref.10 |
| Involvement in disease | Progressive external ophthalmoplegia with mitochondrial DNA deletions autosomal dominant 3 (PEOA3) [MIM:609286]: A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) [MIM:607459]: A systemic disorder resulting from mitochondrial dysfunction associated with mitochondrial depletion in skeletal muscle and peripheral nerve tissue. The clinical triad of symptoms consists of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis. However, the phenotype varies widely, even within the same family, and can also include myopathy, seizures, and hearing loss. An atypical form of the disease is characterized by headaches and/or seizures manifesting in childhood or adolescence, followed by development of cerebellar and sensory ataxia, dysarthria, progressive external ophthalmoplegia, and myoclonus in early adulthood. Mitochondrial DNA depletion syndrome 7 (MTDPS7) [MIM:271245]: A severe disease associated with mitochondrial dysfunction. Some patients are affected by progressive atrophy of the cerebellum, brain stem, the spinal cord, and sensory axonal neuropathy. Clinical features include hypotonia, athetosis, ataxia, ophthalmoplegia, sensorineural hearing deficit, sensory axonal neuropathy, epileptic encephalopathy and female hypogonadism. In some individuals liver dysfunction and multi-organ failure is present. |
| Sequence similarities | Contains 1 SF4 helicase domain. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96RR1-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96RR1-2) Also known as: Twinky; The sequence of this isoform differs from the canonical sequence as follows: 579-582: ASQE → VSGL 583-684: Missing. | ||||||
| Isoform 3 (identifier: Q96RR1-3) The sequence of this isoform differs from the canonical sequence as follows: 532-684: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Transit peptide | 1 – 31 | 31 | Mitochondrion Potential | ||||||
| Chain | 32 – 684 | 653 | Twinkle protein, mitochondrial | PRO_0000042640 | |||||
Regions | |||||||||
| Domain | 384 – 635 | 252 | SF4 helicase | ||||||
| Nucleotide binding | 415 – 422 | 8 | ATP By similarity | ||||||
Natural variations | |||||||||
| Alternative sequence | 532 – 684 | 153 | Missing in isoform 3. | VSP_015959 | |||||
| Alternative sequence | 579 – 582 | 4 | ASQE → VSGL in isoform 2. | VSP_015960 | |||||
| Alternative sequence | 583 – 684 | 102 | Missing in isoform 2. | VSP_015961 | |||||
| Natural variant | 303 | 1 | R → Q in PEOA3. Ref.25 Ref.28 | VAR_065102 | |||||
| Natural variant | 303 | 1 | R → W in PEOA3; also detected in a case showing digenic inheritance. Ref.15 Ref.23 Ref.26 Ref.28 | VAR_023647 | |||||
| Natural variant | 315 | 1 | W → L in PEOA3. Ref.1 | VAR_023648 | |||||
| Natural variant | 315 | 1 | W → S in PEOA3. Ref.23 | VAR_065103 | |||||
| Natural variant | 318 | 1 | A → T in MTDPS7. Ref.21 | VAR_065104 | |||||
| Natural variant | 319 | 1 | K → E in SANDO; the phenotype highly overlaps with PEOA3. Ref.18 | VAR_023649 | |||||
| Natural variant | 319 | 1 | K → T in PEOA3. Ref.16 | VAR_023650 | |||||
| Natural variant | 334 | 1 | R → P in PEOA3. Ref.23 | VAR_065105 | |||||
| Natural variant | 334 | 1 | R → Q in PEO; sporadic case; the patient also carries the S-848 mutation in the POLG gene suggesting digenic inheritance. Ref.14 Ref.15 Ref.28 Corresponds to variant rs28937887 [ dbSNP | Ensembl ]. | VAR_023651 | |||||
| Natural variant | 335 | 1 | P → L in PEOA3. Ref.12 | VAR_023652 | |||||
| Natural variant | 348 | 1 | G → R. Ref.4 | VAR_062268 | |||||
| Natural variant | 354 | 1 | R → P in PEOA3. Ref.1 Ref.28 | VAR_023653 | |||||
| Natural variant | 357 | 1 | R → P in PEOA3. Ref.22 Ref.28 | VAR_065106 | |||||
| Natural variant | 359 | 1 | A → T in PEOA3. Ref.1 Ref.28 | VAR_023654 | |||||
| Natural variant | 360 | 1 | L → G in MTDPS7; patients manifest multi-organ failure; requires 2 nucleotide substitutions. Ref.27 | VAR_065107 | |||||
| Natural variant | 362 | 1 | A → P in PEOA3. Ref.28 | VAR_065108 | |||||
| Natural variant | 363 | 1 | W → L in PEOA3. Ref.28 | VAR_065109 | |||||
| Natural variant | 367 | 1 | I → T in PEOA3. Ref.1 | VAR_023655 | |||||
| Natural variant | 368 | 1 | V → I. Ref.1 Ref.4 Ref.13 Ref.19 Corresponds to variant rs17113613 [ dbSNP | Ensembl ]. | VAR_023656 | |||||
| Natural variant | 369 | 1 | S → P in PEOA3. Ref.1 | VAR_023657 | |||||
| Natural variant | 369 | 1 | S → Y in PEOA3. Ref.12 | VAR_023658 | |||||
| Natural variant | 370 | 1 | F → C in PEOA3. Ref.28 | VAR_065110 | |||||
| Natural variant | 370 | 1 | F → L in PEOA3. Ref.24 | VAR_065111 | |||||
| Natural variant | 374 | 1 | R → Q in PEOA3. Ref.1 Ref.19 Ref.28 Ref.29 | VAR_023659 | |||||
| Natural variant | 381 | 1 | L → P in PEOA3. Ref.1 Ref.28 | VAR_023660 | |||||
| Natural variant | 426 | 1 | S → N in PEOA3. Ref.23 | VAR_065112 | |||||
| Natural variant | 427 | 1 | E → G. Corresponds to variant rs11542126 [ dbSNP | Ensembl ]. | VAR_051267 | |||||
| Natural variant | 456 | 1 | L → V in MTDPS7; infantile spinocerebellar ataxia phenotype. Ref.30 | VAR_067722 | |||||
| Natural variant | 457 | 1 | T → I in MTDPS7; affects helicase activity. Ref.20 | VAR_039045 | |||||
| Natural variant | 458 | 1 | Q → H in PEOA3. Ref.28 | VAR_065113 | |||||
| Natural variant | 460 | 1 | A → P in PEOA3. Ref.28 | VAR_065114 | |||||
| Natural variant | 474 | 1 | W → C in PEOA3. Ref.1 | VAR_023661 | |||||
| Natural variant | 474 | 1 | W → S in PEOA3. Ref.23 | VAR_065115 | |||||
| Natural variant | 475 | 1 | A → D in PEOA3. Ref.28 | VAR_065116 | |||||
| Natural variant | 475 | 1 | A → P in PEOA3. Ref.1 | VAR_023662 | |||||
| Natural variant | 478 | 1 | F → I in PEOA3. Ref.23 | VAR_065117 | |||||
| Natural variant | 479 | 1 | E → K in PEOA3. Ref.23 Ref.28 | VAR_065118 | |||||
| Natural variant | 508 | 1 | Y → C in MTDPS7. Ref.17 Ref.21 | VAR_043797 | |||||
| Natural variant | 634 | 1 | N → K. Ref.4 | VAR_062269 | |||||
Experimental info | |||||||||
| Sequence conflict | 351 | 1 | N → D in CAE45905. Ref.3 | ||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human mitochondrial DNA deletions associated with mutations in the gene for Twinkle, a phage T7 gene 4-like protein localized in mitochondria." Spelbrink J.N., Li F.-Y., Tiranti V., Nikali K., Yuan Q.-P., Tariq M., Wanrooij S., Garrido N., Comi G., Morandi L., Santoro L., Toscano A., Fabrizi G.-M., Somer H., Croxen R., Beeson D., Poulton J., Suomalainen A. Larsson C.Nat. Genet. 28:223-231(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, SUBCELLULAR LOCATION, VARIANT ILE-368, VARIANTS PEOA3 LEU-315; PRO-354; THR-359; THR-367; PRO-369; GLN-374; PRO-381; CYS-474 AND PRO-475. |
| [2] | Erratum Spelbrink J.N., Li F.-Y., Tiranti V., Nikali K., Yuan Q.-P., Tariq M., Wanrooij S., Garrido N., Comi G., Morandi L., Santoro L., Toscano A., Fabrizi G.-M., Somer H., Croxen R., Beeson D., Poulton J., Suomalainen A. Larsson C.Nat. Genet. 29:100-100(2001) |
| [3] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Fetal brain. |
| [4] | NIEHS SNPs program Submitted (MAR-2008) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ARG-348; ILE-368 AND LYS-634. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 10." Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., Taylor A., Battles J. Rogers J.Nature 429:375-381(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 132-582 (ISOFORM 2). Tissue: Skin. |
| [8] | "TWINKLE has 5' -> 3' DNA helicase activity and is specifically stimulated by mitochondrial single-stranded DNA-binding protein." Korhonen J.A., Gaspari M., Falkenberg M. J. Biol. Chem. 278:48627-48632(2003) [PubMed] [Europe PMC] [Abstract] Cited for: PROBABLE FUNCTION. |
| [9] | "Reconstitution of a minimal mtDNA replisome in vitro." Korhonen J.A., Pham X.H., Pellegrini M., Falkenberg M. EMBO J. 23:2423-2429(2004) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, INTERACTION WITH POLG. |
| [10] | "Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number." Tyynismaa H., Sembongi H., Bokori-Brown M., Granycome C., Ashley N., Poulton J., Jalanko A., Spelbrink J.N., Holt I.J., Suomalainen A. Hum. Mol. Genet. 13:3219-3227(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, COREGULATION WITH MRPL43. |
| [11] | "Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA." Wanrooij S., Luoma P., van Goethem G., van Broeckhoven C., Suomalainen A., Spelbrink J.N. Nucleic Acids Res. 32:3053-3064(2004) [PubMed] [Europe PMC] [Abstract] Cited for: POSSIBLE MECHANISM OF DELETION FORMATION. |
| [12] | "Clinical and molecular features of adPEO due to mutations in the Twinkle gene." Lewis S., Hutchison W., Thyagarajan D., Dahl H.-H.M. J. Neurol. Sci. 201:39-44(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PEOA3 LEU-335 AND TYR-369. |
| [13] | "The V368I mutation in Twinkle does not segregate with AdPEO." Arenas J., Briem E., Dahl H.-H.M., Hutchison W., Lewis S., Martin M.A., Spelbrink H., Tiranti V., Jacobs H., Zeviani M. Ann. Neurol. 53:278-278(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT ILE-368. |
| [14] | "Digenic progressive external ophthalmoplegia in a sporadic patient: recessive mutations in POLG and C10orf2/Twinkle." Van Goethem G., Loefgren A., Dermaut B., Ceuterick C., Martin J.-J., Van Broeckhoven C. Hum. Mutat. 22:175-176(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEO GLN-334. |
| [15] | "Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO)." Agostino A., Valletta L., Chinnery P.F., Ferrari G., Carrara F., Taylor R.W., Schaefer A.M., Turnbull D.M., Tiranti V., Zeviani M. Neurology 60:1354-1356(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PEO TRP-303 AND GLN-334. |
| [16] | "A novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia." Deschauer M., Kiefer R., Blakely E.L., He L., Zierz S., Turnbull D.M., Taylor R.W. Neuromuscul. Disord. 13:568-572(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEOA3 THR-319. |
| [17] | "Infantile onset spinocerebellar ataxia is caused by recessive mutations in mitochondrial proteins Twinkle and Twinky." Nikali K., Suomalainen A., Saharinen J., Kuokkanen M., Spelbrink J.N., Loennqvist T., Peltonen L. Hum. Mol. Genet. 14:2981-2990(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MTDPS7 CYS-508. |
| [18] | "Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism." Hudson G., Deschauer M., Busse K., Zierz S., Chinnery P.F. Neurology 64:371-373(2005) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT SANDO GLU-319. |
| [19] | "Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay." Naiemi M., Bannwarth S., Procaccio V., Pouget J., Desnuelle C., Pellissier J.-F., Roetig A., Munnich A., Calvas P., Richelme C., Jonveaux P., Castelnovo G., Simon M., Clanet M., Wallace D., Paquis-Flucklinger V. Eur. J. Hum. Genet. 14:917-922(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEOA3 GLN-374, VARIANT ILE-368. |
| [20] | "Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion." Sarzi E., Goffart S., Serre V., Chretien D., Slama A., Munnich A., Spelbrink J.N., Roetig A. Ann. Neurol. 62:579-587(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MTDPS7 ILE-457, CHARACTERIZATION OF VARIANT MTDPS7 ILE-457. |
| [21] | "Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion." Hakonen A.H., Isohanni P., Paetau A., Herva R., Suomalainen A., Lonnqvist T. Brain 130:3032-3040(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS MTDPS7 THR-318 AND CYS-508. |
| [22] | "Mild ocular myopathy associated with a novel mutation in mitochondrial twinkle helicase." Rivera H., Blazquez A., Carretero J., Alvarez-Cermeno J.C., Campos Y., Cabello A., Gonzalez-Vioque E., Borstein B., Garesse R., Arenas J., Martin M.A. Neuromuscul. Disord. 17:677-680(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEOA3 PRO-357. |
| [23] | "Novel Twinkle (PEO1) gene mutations in Mendelian progressive external ophthalmoplegia." Virgilio R., Ronchi D., Hadjigeorgiou G.M., Bordoni A., Saladino F., Moggio M., Adobbati L., Kafetsouli D., Tsironi E., Previtali S., Papadimitriou A., Bresolin N., Comi G.P. J. Neurol. 255:1384-1391(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PEOA3 TRP-303; SER-315; PRO-334; ASN-426; SER-474; ILE-478 AND LYS-479. |
| [24] | "Phenotype and clinical course in a family with a new de novo Twinkle gene mutation." Jeppesen T.D., Schwartz M., Colding-Jorgensen E., Krag T., Hauerslev S., Vissing J. Neuromuscul. Disord. 18:306-309(2008) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEOA3 LEU-370. |
| [25] | "Finding twinkle in the eyes of a 71-year-old lady: a case report and review of the genotypic and phenotypic spectrum of TWINKLE-related dominant disease." Van Hove J.L., Cunningham V., Rice C., Ringel S.P., Zhang Q., Chou P.C., Truong C.K., Wong L.J. Am. J. Med. Genet. A 149:861-867(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEOA3 GLN-303. |
| [26] | "Molecular analysis in a family presenting with a mild form of late-onset autosomal dominant chronic progressive external ophthalmoplegia." Negro R., Zoccolella S., Dell'aglio R., Amati A., Artuso L., Bisceglia L., Lavolpe V., Papa S., Serlenga L., Petruzzella V. Neuromuscul. Disord. 19:423-426(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEOA3 TRP-303. |
| [27] | "Novel Twinkle gene mutation in autosomal dominant progressive external ophthalmoplegia and multisystem failure." Bohlega S., Van Goethem G., Al Semari A., Lofgren A., Al Hamed M., Van Broeckhoven C., Kambouris M. Neuromuscul. Disord. 19:845-848(2009) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MTDPS7 GLY-360. |
| [28] | "The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO." Fratter C., Gorman G.S., Stewart J.D., Buddles M., Smith C., Evans J., Seller A., Poulton J., Roberts M., Hanna M.G., Rahman S., Omer S.E., Klopstock T., Schoser B., Kornblum C., Czermin B., Lecky B., Blakely E.L. Taylor R.W.Neurology 74:1619-1626(2010) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS PEOA3 GLN-303; TRP-303; GLN-334; PRO-354; PRO-357; THR-359; PRO-362; LEU-363; CYS-370; GLN-374; PRO-381; HIS-458; PRO-460; ASP-475 AND LYS-479. |
| [29] | "TWINKLE gene mutation: report of a French family with an autosomal dominant progressive external ophthalmoplegia and literature review." Martin-Negrier M.L., Sole G., Jardel C., Vital C., Ferrer X., Vital A. Eur. J. Neurol. 18:436-441(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT PEOA3 GLN-374. |
| [30] | "Identification of a novel Twinkle mutation in a family with infantile onset spinocerebellar ataxia by whole exome sequencing." Dundar H., Ozgul R.K., Yalnizoglu D., Erdem S., Oguz K.K., Tuncel D., Temucin C.M., Dursun A. Pediatr. Neurol. 46:172-177(2012) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT MTDPS7 VAL-456. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF292004 mRNA. Translation: AAK69558.1. AF292005 mRNA. Translation: AAK69559.1. BX640829 mRNA. Translation: CAE45905.1. AL133215 Genomic DNA. Translation: CAI10924.1. EU543650 Genomic DNA. Translation: ACB21043.1. AL133215 Genomic DNA. Translation: CAI10925.1. CH471066 Genomic DNA. Translation: EAW49794.1. BC013349 mRNA. Translation: AAH13349.1. |
| IPI | IPI00102660. IPI00640641. IPI00654621. |
| RefSeq | NP_001157284.1. NM_001163812.1. NP_068602.2. NM_021830.4. |
| UniGene | Hs.22678. |
3D structure databases | |
| ProteinModelPortal | Q96RR1. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q96RR1. 3 interactions. |
| MINT | MINT-1385725. |
| STRING | 9606.ENSP00000309595. |
PTM databases | |
| PhosphoSite | Q96RR1. |
Polymorphism databases | |
| DMDM | 74752111. |
Proteomic databases | |
| PaxDb | Q96RR1. |
| PRIDE | Q96RR1. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000311916; ENSP00000309595; ENSG00000107815. ENST00000370228; ENSP00000359248; ENSG00000107815. |
| GeneID | 56652. |
| KEGG | hsa:56652. |
| UCSC | uc001ksf.2. human. uc001ksg.2. human. |
Organism-specific databases | |
| CTD | 56652. |
| GeneCards | GC10P102738. |
| HGNC | HGNC:1160. C10orf2. |
| HPA | HPA002532. |
| MIM | 271245. phenotype. 606075. gene. 607459. phenotype. 609286. phenotype. |
| neXtProt | NX_Q96RR1. |
| Orphanet | 254892. Autosomal dominant progressive external ophthalmoplegia. 1186. Infantile onset spinocerebellar ataxia. |
| PharmGKB | PA162377675. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG29349. |
| HOGENOM | HOG000273872. |
| HOVERGEN | HBG059782. |
| InParanoid | Q96RR1. |
| OMA | GSWEDFQ. |
| OrthoDB | EOG434W5N. |
| PhylomeDB | Q96RR1. |
Gene expression databases | |
| ArrayExpress | Q96RR1. |
| Bgee | Q96RR1. |
| CleanEx | HS_C10orf2. |
| Genevestigator | Q96RR1. |
| GermOnline | ENSG00000107815. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR007694. DNA_helicase_DnaB-like_C. IPR027032. Twinkle. [Graphical view] |
| PANTHER | PTHR12873. PTHR12873. 1 hit. |
| PROSITE | PS51199. SF4_HELICASE. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| GenomeRNAi | 56652. |
| NextBio | 62113. |
| SOURCE | Search... |
Entry information
| Entry name | PEO1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96RR1 Secondary accession number(s): B2CQL2 Q96RR0 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 10 Human chromosome 10: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
